Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Dubrofsky

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Canadian Journal of Cardiology|April 30, 2019
Guideline Alignment in Related AreasLisa Dubrofsky, Sheldon W Tobe
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 18, 2023
Screening for primary aldosteronism in primary careLisa Dubrofsky, Gregory L Hundemer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 12, 2023
Lisa Dubrofsky, Gregory L Hundemer
Hypertension (Dallas, Tex. : 1979)|December 7, 2022
Hypertension and an Incidental Neck Mass in a 20-Year-Old WomanLisa Dubrofsky, Paula J Harvey
Canadian Journal of Kidney Health and Disease|July 9, 2020
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative ReviewLisa Dubrofsky, Anand Srivastava, David Z Cherney
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 23, 2026
Management of chronic kidney disease in a 65-year-old man with diabetesLisa Dubrofsky, David Z I Cherney, Ayodele Odutayo
The Canadian Journal of Cardiology|February 25, 2026
Recalibrate your opinion about the aneroid sphygmomanometer for blood pressure measurementSheldon W Tobe, Lisa Dubrofsky, Sachin V Pasricha
Kidney International|November 19, 2015
The Case | Hypercalcemia in a renal transplant recipientLisa Dubrofsky, Mark L Lipman, Sharon J Nessim
Jornal Brasileiro De Nefrologia|September 14, 2020
Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protectionVikas S Sridhar, Lisa Dubrofsky, Jacinthe Boulet, et al.
Expert Review of Cardiovascular Therapy|December 16, 2022
The anti-hypertensive effects of sodium-glucose cotransporter-2 inhibitorsLuxcia Kugathasan, Lisa Dubrofsky, Andrew Advani, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Cardiology|April 30, 2019
Guideline Alignment in Related AreasLisa Dubrofsky, Sheldon W Tobe
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 18, 2023
Screening for primary aldosteronism in primary careLisa Dubrofsky, Gregory L Hundemer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 12, 2023
Lisa Dubrofsky, Gregory L Hundemer
Hypertension (Dallas, Tex. : 1979)|December 7, 2022
Hypertension and an Incidental Neck Mass in a 20-Year-Old WomanLisa Dubrofsky, Paula J Harvey
Canadian Journal of Kidney Health and Disease|July 9, 2020
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative ReviewLisa Dubrofsky, Anand Srivastava, David Z Cherney
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 23, 2026
Management of chronic kidney disease in a 65-year-old man with diabetesLisa Dubrofsky, David Z I Cherney, Ayodele Odutayo
The Canadian Journal of Cardiology|February 25, 2026
Recalibrate your opinion about the aneroid sphygmomanometer for blood pressure measurementSheldon W Tobe, Lisa Dubrofsky, Sachin V Pasricha
Kidney International|November 19, 2015
The Case | Hypercalcemia in a renal transplant recipientLisa Dubrofsky, Mark L Lipman, Sharon J Nessim
Jornal Brasileiro De Nefrologia|September 14, 2020
Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protectionVikas S Sridhar, Lisa Dubrofsky, Jacinthe Boulet, et al.
Expert Review of Cardiovascular Therapy|December 16, 2022
The anti-hypertensive effects of sodium-glucose cotransporter-2 inhibitorsLuxcia Kugathasan, Lisa Dubrofsky, Andrew Advani, et al.
Pageof 3